Article Details

Biohaven Pharmaceutical's (BHVN) “Hold” Rating Reiterated at Barclays

Retrieved on: 2019-03-15 22:15:00

Tags for this article:

Click the tags to see associated articles and topics

Biohaven Pharmaceutical's (BHVN) “Hold” Rating Reiterated at Barclays. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc bought a new stake in shares of Biohaven Pharmaceutical during the third quarter valued at about $4,996,000. Emerald ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up